https://pharmadog.xyz/news/574511 pharmadog en 2026-10-21T21:38:41.000Z CMS expands fraud crackdown to New York adult day-care program, calls it a "plague to the state" https://pharmadog.xyz/news/574402 pharmadog en 2026-10-21T20:24:00.000Z Wedgewood Pharmacy recalls multiple compounded veterinary meds over potency testing inconsistencies https://pharmadog.xyz/news/574067 pharmadog en 2026-10-21T19:59:48.000Z ADA chief scientific officer Rita Kalyani departs amid ongoing review of New Orleans incident https://pharmadog.xyz/news/573855 pharmadog en 2026-10-21T18:48:02.000Z Treasury to tighten scrutiny of China biotech acquisitions under upcoming rules https://pharmadog.xyz/news/573731 pharmadog en 2026-10-21T17:49:31.000Z Isomorphic Labs' soaring valuation sparks debate over AI’s impact on drug development and healthcare costs https://pharmadog.xyz/news/573687 pharmadog en 2026-10-21T17:04:27.000Z Samsung Biologics union vows appeal after court blocks planned strike https://pharmadog.xyz/news/573435 pharmadog en 2026-10-21T16:49:10.000Z FDA cites Baxter’s inadequate oversight after repeated GMP violations at multiple plants https://pharmadog.xyz/news/573475 pharmadog en 2026-10-21T16:03:00.000Z GSK and Ionis receive FDA nod for Hibsago, a potential functional cure for chronic hepatitis B https://pharmadog.xyz/news/573307 pharmadog en 2026-10-21T15:31:00.000Z Roivant's brepocitinib shows strong Phase 3 results, paving way for uveitis indication https://pharmadog.xyz/news/573243 pharmadog en 2026-10-21T15:15:31.000Z Endpoints AI Day highlights agents, AI slop and biosecurity gaps in pharma https://pharmadog.xyz/news/573244 pharmadog en 2026-10-21T15:11:08.000Z CSL appoints former ViiV and GSK veteran Deborah Waterhouse as new CEO https://pharmadog.xyz/news/573075 pharmadog en 2026-10-21T14:57:33.000Z Alcon buys Neurotech for $550 million upfront https://pharmadog.xyz/news/573076 pharmadog en 2026-10-21T14:39:09.000Z Roivant's autoimmune drug brepocitinib succeeds in two pivotal trials, paving way for 2027 filing https://pharmadog.xyz/news/573119 pharmadog en 2026-10-21T14:24:45.000Z GSK receives FDA approval for hepatitis B therapy that expands functional cure rates https://pharmadog.xyz/news/573139 pharmadog en 2026-10-21T14:23:00.000Z Arcus kidney cancer drug shows stronger potency than Merck's Welireg, boosting shares https://pharmadog.xyz/news/572931 pharmadog en 2026-10-21T13:49:32.000Z Eight biopharma companies posting dozens of remote job openings https://pharmadog.xyz/news/134233 pharmadog en 2026-10-21T13:43:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/572932 pharmadog en 2026-10-21T13:34:33.000Z US patients skip half of new high-cost drugs as prices surge past $250K https://pharmadog.xyz/news/572951 pharmadog en 2026-10-21T13:26:27.000Z Mark Cuban’s Cost Plus Drugs plans to enter custom rare-disease drug market https://pharmadog.xyz/news/572933 pharmadog en 2026-10-21T13:18:35.000Z Disc Medicine’s Phase 3 data revives rejected rare‑disease drug as China tightens biotech ownership rules https://pharmadog.xyz/news/572934 pharmadog en 2026-10-21T13:16:50.000Z FDA approves GSK‑Ionis hepatitis B functional cure, Hibsago, targeting undetectable virus after six months https://pharmadog.xyz/news/572783 pharmadog en 2026-10-21T12:05:54.000Z Roivant reports Lisraya beats placebo in Phase 3 trials for non-infectious uveitis https://pharmadog.xyz/news/572763 pharmadog en 2026-10-21T12:00:44.000Z Novo reports 25% average weight loss in women using CagriSema, with greatest loss in premenopausal patients https://pharmadog.xyz/news/572615 pharmadog en 2026-10-21T11:54:47.000Z Nigeria confirms travel-linked Ebola case tied to DRC outbreak https://pharmadog.xyz/news/123087 pharmadog en 2026-10-21T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/572295 pharmadog en 2026-10-21T10:12:55.000Z GSK and Ionis receive FDA nod for hepatitis B therapy promising functional cure https://pharmadog.xyz/news/573050 pharmadog en 2026-10-21T09:37:00.000Z Amid bepirovirsen triumph, GSK quietly scraps trial of next-gen hep B therapy https://pharmadog.xyz/news/572882 pharmadog en 2026-10-21T09:30:00.000Z Roche reports up to 30% shrinkage of chronic MS lesions with fenebrutinib, eyes FDA approval https://pharmadog.xyz/news/573052 pharmadog en 2026-10-21T09:16:00.000Z Astellas partners with AI Proteins on $400M computational drug discovery deal https://pharmadog.xyz/news/572004 pharmadog en 2026-10-21T08:30:00.000Z Mark Cuban's Cost Plus Drugs targets rare disease market with custom n-of-1 therapies https://pharmadog.xyz/news/572007 pharmadog en 2026-10-21T08:30:00.000Z German biotech Immatics eyes pivotal Phase 3 readout after promising uveal melanoma cell therapy results https://pharmadog.xyz/news/572005 pharmadog en 2026-10-21T08:30:00.000Z NIH Scales Back Replication Initiative, Critics Warn It Undermines Scientific Rigor https://pharmadog.xyz/news/572003 pharmadog en 2026-10-21T08:30:00.000Z Experts suggest emphasizing measles survival rates to boost vaccine trust https://pharmadog.xyz/news/572006 pharmadog en 2026-10-21T08:30:00.000Z Rising US measles cases highlight need for door-to-door public health outreach https://pharmadog.xyz/news/571515 pharmadog en 2026-10-21T06:00:22.000Z Lilly advances retatrutide toward sleep-apnea market https://pharmadog.xyz/news/571203 pharmadog en 2026-10-21T04:12:00.000Z Crossover fundraisings may hit $4.2 billion in 2026, with 2025 rounds still leading historic totals https://pharmadog.xyz/news/571205 pharmadog en 2026-10-21T04:01:00.000Z Companies price the role, not the employee, says executive coach on compensation expectations https://pharmadog.xyz/news/571204 pharmadog en 2026-10-21T04:01:00.000Z US biotech M&A surges as Chinese licensing deals dominate 2026 market https://pharmadog.xyz/news/571934 pharmadog en 2026-10-21T03:13:00.000Z Biotech reverse mergers surge in 2026, reaching highest level since 2021 as PIPE financing spikes https://pharmadog.xyz/news/573392 pharmadog en 2026-10-21T02:18:00.000Z Myriad Genetics sells prenatal testing business to Labcorp for $210 million https://pharmadog.xyz/news/573393 pharmadog en 2026-10-21T02:11:00.000Z Hologic acquires Spain’s Reveal Genomics to expand breast cancer genomic testing https://pharmadog.xyz/news/569831 pharmadog en 2026-10-20T21:22:26.000Z Nursing home cuts resident care while diverting revenue to real estate, state oversight lacking https://pharmadog.xyz/news/569663 pharmadog en 2026-10-20T20:14:29.000Z Massachusetts moves to revoke all RegalCare nursing home licenses after Boston Globe investigation https://pharmadog.xyz/news/569534 pharmadog en 2026-10-20T19:40:38.000Z FDA approves Hibsago, first antisense therapy for chronic hepatitis B https://pharmadog.xyz/news/569007 pharmadog en 2026-10-20T17:57:40.000Z ICER report finds median launch drug prices jumped 24% between 2022 and 2025 https://pharmadog.xyz/news/568883 pharmadog en 2026-10-20T16:47:02.000Z Lawmakers push FDA to close loophole allowing import of counterfeit Eli Lilly obesity drug https://pharmadog.xyz/news/568884 pharmadog en 2026-10-20T16:42:06.000Z Roche signs major partnership with China's Hansoh to co-develop antibody-drug conjugates https://pharmadog.xyz/news/568903 pharmadog en 2026-10-20T16:27:00.000Z Rapport Therapeutics' epilepsy drug RAP-219 meets primary endpoint in bipolar mania Phase II trial https://pharmadog.xyz/news/568922 pharmadog en 2026-10-20T15:57:36.000Z FDA approves first generic weekly hormone patch for menopausal women https://pharmadog.xyz/news/568904 pharmadog en 2026-10-20T15:55:00.000Z ICER reports two-thirds of new drugs launched 2022-2025 priced well above cost-effectiveness thresholds https://pharmadog.xyz/news/568715 pharmadog en 2026-10-20T15:41:10.000Z Reporter urges audiences to skip new Elizabeth Holmes documentary https://pharmadog.xyz/news/568563 pharmadog en 2026-10-20T15:15:18.000Z Epic introduces prescription marketplace to let doctors and patients compare drug prices https://pharmadog.xyz/news/573218 pharmadog en 2026-10-20T15:10:00.000Z Researchers develop tumor "avatar" model that predicts immunotherapy response with 93% accuracy https://pharmadog.xyz/news/568395 pharmadog en 2026-10-20T14:55:11.000Z Pfizer halts Phase 2 trial of PF-06835375 in primary immune thrombocytopenia https://pharmadog.xyz/news/568439 pharmadog en 2026-10-20T14:40:13.000Z JAMA paper on OpenEvidence highlights clinician use but raises unanswered questions https://pharmadog.xyz/news/568440 pharmadog en 2026-10-20T14:02:16.000Z Median net price of new drugs jumps 35% from 2022 to 2025, reaching $257,000 https://pharmadog.xyz/news/568419 pharmadog en 2026-10-20T14:00:59.000Z Rapport Therapeutics reports Phase 2 success for RAP-219 in bipolar mania trial https://pharmadog.xyz/news/568227 pharmadog en 2026-10-20T13:49:20.000Z Biopharma Sentiment Index climbs to upbeat 105 in Q3 2026, marking strongest optimism in years https://pharmadog.xyz/news/568252 pharmadog en 2026-10-20T13:40:12.000Z BioSpace podcast highlights Q3 job market gains and sharp layoff decline for biopharma talent https://pharmadog.xyz/news/568103 pharmadog en 2026-10-20T12:55:52.000Z New poll gauges U.S. voter attitudes toward transgender sports participation and abortion access https://pharmadog.xyz/news/568253 pharmadog en 2026-10-20T12:54:15.000Z Lilly commits up to $1.1 billion to Hong Kong biotech METiS TechBio's AI-driven lipid nanoparticle platform https://pharmadog.xyz/news/568104 pharmadog en 2026-10-20T12:37:18.000Z Dana-Farber and Beth Israel Lahey Health break ground on $1.68 billion cancer hospital in Boston https://pharmadog.xyz/news/568059 pharmadog en 2026-10-20T12:00:46.000Z Astellas teams up with Boston miniprotein startup to explore AI-designed tiny proteins https://pharmadog.xyz/news/568123 pharmadog en 2026-10-20T12:00:00.000Z Pharma pours billions into bispecifics, ADCs and cell therapies despite limited clinical proof https://pharmadog.xyz/news/568084 pharmadog en 2026-10-20T11:56:15.000Z Gilead’s emvistegrast shows superior response to placebo in Phase 2 ulcerative colitis trial https://pharmadog.xyz/news/567891 pharmadog en 2026-10-20T11:14:39.000Z Rapport Therapeutics reports Phase 2 success for J&J-licensed bipolar mania drug https://pharmadog.xyz/news/567767 pharmadog en 2026-10-20T10:30:00.000Z New drug launch prices climb 35% to $257,000 median, with a quarter exceeding $500,000 https://pharmadog.xyz/news/571766 pharmadog en 2026-10-20T10:08:00.000Z SCRS unveils Eagle Insights Dashboard to benchmark clinical trial site performance https://pharmadog.xyz/news/568202 pharmadog en 2026-10-20T09:20:00.000Z Rapport Therapeutics' Phase 2 Bipolar Mania Trial Meets Primary Endpoint, Though Effect Size Below Target https://pharmadog.xyz/news/567324 pharmadog en 2026-10-20T08:30:00.000Z Proposed ACGME rule changes could strip resident doctors of mandatory rest periods https://pharmadog.xyz/news/567323 pharmadog en 2026-10-20T08:30:00.000Z Midterm ballot measures spotlight abortion, transgender rights and Medicaid expansion https://pharmadog.xyz/news/568370 pharmadog en 2026-10-20T07:50:00.000Z Lycia Therapeutics targets $228M IPO to fund food allergy protein degrader programs https://pharmadog.xyz/news/566968 pharmadog en 2026-10-20T06:00:00.000Z BioSpace releases Q3 2026 biopharma job market report showing upbeat hiring trends https://pharmadog.xyz/news/568817 pharmadog en 2026-10-20T04:44:00.000Z EY report says MedTech growth driven by commercial leaders, AI and expanding into new care settings https://pharmadog.xyz/news/538247 pharmadog en 2026-10-20T04:29:00.000Z Alnylam shares tumble to $250 after cutting full-year revenue guidance for its TTR franchise https://pharmadog.xyz/news/566525 pharmadog en 2026-10-20T04:15:00.000Z Genmab faces steep revenue cliff as Darzalex patents expire, eyes pivotal Epkinly readout https://pharmadog.xyz/news/567254 pharmadog en 2026-10-20T04:03:00.000Z Pfizer halts phase 2 trial of CXCR5 antibody for immune thrombocytopenia https://pharmadog.xyz/news/569110 pharmadog en 2026-10-20T04:00:00.000Z Cardinal Health issues updated instructions for Presource kits containing recalled BD Alaris infusion sets https://pharmadog.xyz/news/569557 pharmadog en 2026-10-20T04:00:00.000Z FDA issues import alert on Olympus endoscopic devices over quality violations https://pharmadog.xyz/news/568942 pharmadog en 2026-10-20T04:00:00.000Z Nova Biomedical pulls Gen 2.0 StatStrip hospital glucose meters over patient ID software flaw https://pharmadog.xyz/news/566918 pharmadog en 2026-10-20T02:37:00.000Z AstraZeneca partners with Oracle to boost clinical trial patient recruitment using AI https://pharmadog.xyz/news/569525 pharmadog en 2026-10-20T00:00:00.000Z AstraZeneca teams with Oracle on AI-driven clinical trials as FDA clears Haemonetics vascular closure system https://pharmadog.xyz/news/570029 pharmadog en 2026-10-20T00:00:00.000Z FDA and UK regulators discuss new frameworks for generative AI oversight https://pharmadog.xyz/news/570030 pharmadog en 2026-10-20T00:00:00.000Z FDA issues final guidance on developing and labeling prescription drug apps